About

Piergiorgio Muriana is a thoracic surgeon and clinical researcher whose work sits at the forefront of minimally invasive and robotic-assisted thoracic surgery, with a particular focus on lung cancer treatment. His most significant contribution to the field is his leadership of the ROMAN Study, the first prospective international randomized controlled trial comparing robotic-assisted thoracic surgery (RATS) with traditional video-assisted thoracoscopic surgery (VATS) for early-stage lung cancer — a landmark paper that has accumulated 94 citations since its 2021 publication and established an important evidence base for surgical decision-making. Muriana has further advanced the field by evaluating next-generation robotic platforms, including comparative studies of the Toumai® and da Vinci systems, and by investigating specific postoperative complications such as prolonged air leak following robotic resection. Notably, his recent research extends robotic techniques to underserved patient populations, demonstrating the safety of RATS in very elderly patients and those with locally advanced non-small cell lung cancer. Across his body of work, Muriana consistently champions evidence-driven adoption of robotic surgery, making his research essential reading for surgeons and trainees navigating the evolving landscape of thoracic oncology.

Research Focus

Key Achievements

3
H-Index
5
Papers
118
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative Outcome of Robotic Approach Versus Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study)
94 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Vita-Salute San Raffaele University, San Raffaele University of Rome, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago